Capital Flow Monitor · Sponsors · CIK 1780950
ByHeart, Inc.
131 Varick Street, New York, NY, 10013 · 646-933-3208
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$95.5M
Sold
$95.5M
% sold
100.0%
Investors
46
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | D/A ·current | 506(b) | $95.5M | $95.5M | 100.0% | 46 | EDGAR ↗ |
| 2026-03-31 | D/A | 506(b) | $173.1M | $72.2M | 41.7% | 49 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Ron Belldegrun — Executive Officer / Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Georg Krause-Vilmar — Executive Officer, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Mia B. Funt — Executive Officer / Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Devon Kuehn — Executive Officer, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Niall Mullane — Executive Officer, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Arie Belldegrun — Director, New York, NY
9 other raises
- Vida Ventures IV, L.P. $0 of $500.0M · 0.0%
- Healthcare Credit Quantum Alpha Co-Invest, L.P. $0 of —
- Symbiotic Capital Life Science Credit Parallel Fund, L.P. $176.4M of —
- Symbiotic Capital Life Science Credit Fund, L.P. $160.2M of —
- SC Life Science Credit Parallel Fund A, L.P. $242.4M of —
- 3030 Science Park REIT, L.L.C. $250K of $250K · 100.0%
- Symbiotic Capital Healthcare Credit Parallel Fund II, L.P. $137.9M of —
- Symbiotic Capital Healthcare Credit Fund II, L.P. $67.5M of —
- SC Healthcare Credit Parallel Fund II A, L.P. $100.0M of —
-
Joshua Bradley — Director, New York, NY
9 other raises
- Breakthrough Properties Growth Portfolio II, L.P. $280.0M of —
- Healthcare Credit Quantum Alpha Co-Invest, L.P. $0 of —
- Symbiotic Capital Life Science Credit Parallel Fund, L.P. $176.4M of —
- Symbiotic Capital Life Science Credit Fund, L.P. $160.2M of —
- SC Life Science Credit Parallel Fund A, L.P. $242.4M of —
- 3030 Science Park REIT, L.L.C. $250K of $250K · 100.0%
- Symbiotic Capital Healthcare Credit Parallel Fund II, L.P. $137.9M of —
- Symbiotic Capital Healthcare Credit Fund II, L.P. $67.5M of —
- SC Healthcare Credit Parallel Fund II A, L.P. $100.0M of —
-
Joshua Kazam — Director, New York, NY
3 other raises
- Breakthrough Properties Growth Portfolio II, L.P. $280.0M of —
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
- 3030 Science Park REIT, L.L.C. $250K of $250K · 100.0%
- Anton Linderum — Director, New York, NY
-
Guy Oranim — Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Amy Schulman — Director, New York, NY
4 other raises
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
- Sequelae, Inc. $223K of $1.5M · 15.0%
- Polaris Partners XI, L.P. $0 of $500.0M · 0.0%
- QurAlis Corp $20.0M of $24.9M · 80.1%
- Tommy Burke — Director, New York, NY
-
Hemi Zucker — Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
-
Denice Torres — Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
- Elizabeth Abrams — Director, New York, NY
-
Raphael Wallander — Director, New York, NY
1 other raise
- MeridianMade, Inc. $20.3M of $20.3M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.